New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking ...
The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk ...
LNZ100 is a single-use, once-daily eye drop containing aceclidine, a small molecule acetylcholine receptor agonist that causes miosis.
Zacks.com on MSN3d
Avadel Obtains FDA Nod for Label Expansion of Narcolepsy Drug LumryzAvadel Pharmaceuticals plc AVDL announced that the FDA has approved its supplemental new drug application (sNDA) seeking ...
In its new drug application, Stealth BioTherapeutics described elamipretide as a first-in-class mitochondrial protective ...
PDUFA goal date set for June 13, 2025 UGN-102 would be the first FDA-approved medicine for LG-IR-NMIBC, if approved "The FDA acceptance of our NDA is a pivotal moment in our journey to bring UGN ...
A slate of popular policies commonly bandied about to help reduce drug costs would each cut average prices by only a handful of percentage points, according to a recent Congressional Budget Office ...
Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. But with ...
Diet and diabetes drugs like Ozempic and Mounjaro could also help people struggling with alcohol and opioid abuse, according ...
Learn how to effectively navigate the challenges of CMC in breakthrough drug development. Discover key strategies here.
AI-based clinical simulation systems can be a game-changer for the pharmaceutical industry. The ability to predict clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback